tiprankstipranks
Foghorn Therapeutics (FHTX)
NASDAQ:FHTX
US Market
Holding FHTX?
Track your performance easily

Foghorn Therapeutics (FHTX) Financial Statements

119 Followers

Foghorn Therapeutics Financial Overview

Foghorn Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.91; its P/E ratio is -2.69; Foghorn Therapeutics is scheduled to report earnings on March 6, 2025, and the estimated EPS forecast is $-0.31. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 7.81M$ 6.89M$ 5.05M$ 5.77M$ 17.48M
Gross Profit$ 7.81M$ 6.89M$ 5.05M$ 5.77M$ 17.48M
EBIT$ -19.12M$ -22.98M$ -25.75M$ -22.20M$ -13.61M
EBITDA$ -18.32M$ -21.63M$ -25.51M$ -21.80M$ -12.71M
Net Income Common Stockholders$ -19.12M$ -23.76M$ -25.00M$ -24.08M$ -14.35M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 267.40M$ 285.18M$ 206.66M$ 234.06M$ 259.89M
Total Assets$ 308.37M$ 328.58M$ 255.00M$ 285.92M$ 313.42M
Total Debt$ 39.07M$ 40.92M$ 42.98M$ 45.07M$ 47.08M
Net Debt$ -228.33M$ -244.26M$ -163.68M$ -188.98M$ -212.81M
Total Liabilities$ 336.66M$ 342.91M$ 352.49M$ 363.11M$ 370.81M
Stockholders Equity$ -28.29M$ -14.36M$ -97.49M$ -77.19M$ -57.39M
Cash Flow-
Free Cash Flow$ -21.31M$ -25.55M$ -29.45M$ -27.58M$ -27.29M
Operating Cash Flow$ -21.00M$ -25.54M$ -29.34M$ -27.54M$ -27.21M
Investing Cash Flow$ -61.31M$ -17.98M$ 27.09M$ 37.38M$ 38.43M
Financing Cash Flow$ 1.05M$ 103.21M$ 1.17M$ 186.00K$ 1.39M
Currency in USD

Foghorn Therapeutics Earnings and Revenue History

Foghorn Therapeutics Debt to Assets

Foghorn Therapeutics Cash Flow

Foghorn Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis